Renal biopsy-driven molecular target identification in glomerular disease

Area of Science:

• Nephrology
• Genomics
• Biomedical Research

Background:

• Chronic kidney disease (CKD) poses a significant global health burden.
• Current CKD classification lacks molecular specificity, hindering targeted treatment development.
• Advances in biomedical research enable a shift towards molecular understanding of diseases.

Purpose of the Study:

• To introduce precision medicine in nephrology.
• To describe molecular analysis cohort studies in kidney diseases.
• To highlight renal biopsy-driven target identification using systems biology.

Main Methods:

• Review of current literature on precision medicine in nephrology.
• Description of large cohort studies for molecular analysis of kidney diseases.
• Examples of integrative systems biology approaches for target identification.

Main Results:

• Precision medicine enables mechanism-based disease definitions in nephrology.
• Integrative systems biology links tissue structure to molecular function for target identification.
• New disease definitions can improve clinical trial design through patient stratification.

Conclusions:

• Precision medicine is crucial for advancing targeted therapies in nephrology.
• Collaborative, data-rich approaches are essential for understanding kidney diseases.
• An informational commons for renal precision medicine can facilitate large-scale data analysis.